Chick ciliary ganglion neurons have previously been shown to contain a component that shares an antigenic determinant with the "main immunogenic region" of the a-subunit in nicotinic acetylcholine receptor from skeletal muscle and electric organ. Ultrastructural studies of antibody binding in the ganglion have shown that the cross-reacting antigen exposed on the surface of the neurons is located predominantly in synaptic membrane. Here we show that the neuronal antigen can be identified in detergent extracts of ciliary and sympathetic ganglia, but not in extracts of heart, liver, spinal cord, retina, or dorsal root ganglia. In the ciliary ganglion the component is present as an integral membrane constituent, and, when detergent solubilized, it sediments as a 10 S species and binds to concanavalin A. The component is distinct from the a-bungarotoxin-binding site on the neurons since toxin-binding sites and antibody-binding sites can be precipitated separately in ganglion extracts. The component reaches peak levels per ganglionic protein between embryonic days 8 and 12. These are some of the properties expected for the nicotinic acetylcholine receptor on ciliary ganglion neurons.
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organ. In other instances ol-BGT has been found to have no effect on neuronal AChR function (Nurse and O'Lague, 1975; Duggan et al., 1976; Ko et al., 1976; Brown and Fumagalli, 1977; Bursztajn and Gershon, 1977; Patrick and Stallcup, 1977a; Carbonetto et al., 1978; Kouvelas et al., 1978; Ascher et al., 1979; Betz, 1981) .
Mono-and polyclonal antibodies have been used to examine the relationship between toxin-binding sites and AChRs on neurons, and to detect structural homologies between the neuronal toxin sites and muscle and electric organ AChRs. Antisera prepared against purified Torpedo AChR show partial cross-reactivity against the toxin-binding component in rat brain (Block and Billiar, 1979; Wonnacott et al., 1982; Mills and Wonnacott, 1984) and in chick retina (Betz, 1981) . Similarly, partial cross-reactivity was obtained both with an antiserum raised against AChR purified from denervated cat muscle and with a monoclonal antibody (mAb) against AChR from denervated chick muscle when tested against the toxin-binding component from chick brain (Norman et al., 1982; Mehraban et al., 1984) .
Although many populations of central and peripheral vertebrate neurons have nicotinic acetylcholine receptors (AChRs), little progress has been made in characterizing the neuronal receptor. This has been due largely to the lack of suitable probes. ol-Bungarotoxin (a-BGT) has been very useful for studying the muscle and electric organ AChR, but its applicability to the neuronal receptor remains controversial. Many neurons with AChRs also have oc-BGT-binding sites, and in some instances a-BGT has been reported to block receptor function on the neurons (Marshall, 1981; Oswald and Freeman, 1981; Syapin et al., 1982) as it does in muscle and electric Immunological approaches have also revealed AChR-like antigens on neurons that are distinct from the component that binds a-BGT. An antiserum raised against purified AChR from Electrophorus electric organ blocked AChR function on the pheochromocytoma cell line PC1 2 but did not recognize the toxin-binding component on the cells (Patrick and Stallcup, 1977b) . mAbs specific for each of the four subunits of Torpedo AChR cross-react with determinants in the lateral spiriform nucleus in chick brain, although oc-BGT-binding sites in chick brain appear to be excluded from this region (Swanson et al., 1983) . These studies indicate that, although the neuronal toxinbinding component has structural similarities to the muscle AChR and may have related functions, it is premature to equate it with the neuronal AChR. ' The chick ciliary ganglion is an interesting system for studying neuronal AChRs. Chemical transmission through the ganglion is mediated by AChRs on both populations of ganglionic neurons, choroid and ciliary (Martin and Pilar, 1963a, b; Landmesser and Pilar, 1978) . The neurons also have high affinity a-BGT-binding sites, but saturation of the sites with a-BGT does not alter AChR function (Ravdin and Berg, 1979; Chiappinelli et al., 1981; Ravdin et al., 1981) . The number of toxin sites on the neurons in cell culture is regulated independently from the levels of acetylcholine (ACh) sensitivity, suggesting that functional receptors do not correspond to toxin sites in this case (Smith et al., 1983) . A similar conclusion was reached from regulatory studies on PC12 cells in culture (Mitsuka and Hatanaka, 1983) . Moreover, ultrastructural studies on the chick ciliary ganglion indicate that the toxin sites are concentrated on the membrane in the vicinity of synapses but are absent from the postsynaptic membrane itself (Jacob and Berg, 1983) . These results indicate that cY-BGT-binding sites on chick ciliary ganglion neurons are unlikely to represent functional, synaptic AChRs on the cells. against a determinant in the "main immunogenic region" (MIR) of the AChR a-subunit from muscle and electric organ cross-react with a determinant on chick ciliary ganglion neurons. In contrast to the distribution of toxin-binding sites on the neurons, the MIR-like determinant was found to have a predominantly synaptic location (Jacob et al., 1984) . In the present study we have examined some of the biochemical properties of the neuronal component for comparison with known properties of muscle and neuronal AChRs. A preliminary account of this work has appeared (Smith et al., 1984 et al. 1981) to produce "51-mAb 35 with Initial specific activities of 2 to 3 X 1 Oi8 cpm/mol. lz5 I-mAb 35 was stored at 40°C in phosphate-buffered saline containing 0.1% sodium azide and 10 mg/ml of bovrne serum albumin (BSA). lmmedrately before use, aliquots of the labeled antibody were passed through a small DEAE cellulose column to remove material that adsorbed to the resin, thereby reducing backgrounds obtained subsequently in the antibody-binding assay described below. Tissue extracts and membrane fractions. Tissue samples were dissected from 16. to 18.day White Leghorn chick embryos (unless otherwise indicated) and were stored on ice in 11 mM phosphate buffer (pH 7.3) containrng 123 mM NaCI, 5.4 mM KCI, 0.9 mM CaCI,, and 0.4 mM MgSO,. Samples were trimmed free of connectrve trssue and were homogenized at 4°C by hand in 10 mM NaPO,,, pH 7.4, containing 50 mM NaCI, and 0.5% Triton X-100 (homogenization buffer, HB), together with a mixture of protease inhibitors consisting of 5 mM EDTA, 5 mM EGTA, 5 mM phenylmethylsulfonyl fluoride, 10 fig/ml of leupeptin, and 10 pg/ml of pepstatin A. Partrculate debris was removed by centrifugation for 1 min in an Eppendorf microfuge at 15,600 X g, and the supernatant fraction was used in binding studies. To determrne the proportion of mAb-binding sites associated with ciliary ganglion membranes, membrane fragments were prepared by homogenizing ganglia in IO mM NaPO,, pH 7.4, containing either 50 mM or 1 M NaCI, and collectrng the fragments by centnfugation at 26,000 X g for 40 min at 4°C. The membrane fragments were then homogenized in HB and treated as described above to prepare a detergent extract. For comparison, "100%" control values were determined by combining the particulate and supernatant fractions from the frrst centrifugation, adding Triton X-100 to generate HB, recentrifuging the mixture to remove insoluble material, and assaying the resultrng supernatant fraction for mAb 35-binding sites. mAb 35 binding. '251-mAb 35 binding to antigen in detergent extracts was measured by using small DEAE cellulose columns to separate antigenantibody complex (whrch adsorbed to the resin) from free antibody (which passed through the column). Unless otherwise rndrcated, reaction mixtures contarned 5 nM ?mAb 35, normal rat serum (1 :lOO dilution), and the equivalent of one to two ganglra (-10 fig of protein) in 0.020 ml of HB. The reactions were incubated for 1 hr at room temperature, diluted with 0.20 ml of HB, and chromatographed over 0.05.ml DEAE cellulose columns previously equilibrated with HB. Alternatively, triple-size reactions were carried out (0.060 ml with three to six ganglion equrvalents), diluted with 0.60 ml of HB, divrded into three equal aliquots, and chromatographed on separate columns. After rinsing with 2 ml of HB, the columns were gamma counted for radioactrvity.
Nonspecific binding was routinely determined by including a 30. to 50.fold excess of unlabeled mAb 35 in the reaction mixture and subtractrng It from total binding to yield specific binding. Specific binding determined in this way represented greater than 80% of the total radioactivity retarned by the columns in the standard assay. The efficiency of the assay was determined by binding '251-mAb 35 to intact cilrary ganglion neurons grown in cell culture. After washing the cultures to remove free antibody, detergent extracts of the cells were prepared and analyzed to determine the proponron of antigen-antibody complex retained by the column assay. These experiments indicated a retention efficiency of 64% (J. Stollberg, unpublished observations).
The results presented here have been corrected accordingly, except for the sucrose gradient experiments (see below) where no corrections were applied. a-BGT binding. a-BGT was purified from the venom of Bungarus multicmctus (Ravdrn and Berg, 1979) . For quantitative binding studies, the driodo species of ['251]-a-BGT was used; it was prepared and isolated according to the method of Vogel et al. (1972) with specific activities of 2 to 3 x 10" cpm/mol.
In some cases relative levels of toxin binding were determined using ['Z51]-o(-BGT prepared as previously described (Lindstrom et al., 1981) . ['*51]-ol-BGT binding in detergent extracts of chick ciliary ganglia was measured by the method of Meunier et al. (1974) . Reaction volumes of 0.060 ml containing 20 nM ['Z51]-cu-BGT and sample in HB were incubated for 1 hr at room temperature.
The reaction was terminated by diluting 0.020.ml aliquots with 10 ml of cold 10 mM NaP04, pH 7.4, containing 50 mM NaCl (rinse buffer). Under these conditions toxin-receptor complex is preciprtated while free toxin remains in solution. After 30 min at 4°C the sample was passed through a 0.22.pm Millipore filter previously soaked with rinse buffer containing 2 mg/ml of BSA. The filter was then washed with two lo-ml aliquots of cold rinse buffer and was gamma counted for radioactivity. Nonspecific binding, determined by including a 100.fold excess of unlabeled toxin in the initial reaction mixture, was typically 5% of the total radioactivity retarned by the filter and was subtracted in all cases. Aliquots (0.20 ml) of detergent extract prepared from 18.day embryonic ciliary ganglia at a concentration of 200 ganglia/ml were layered onto 4.8-ml IineaFgradients of 5 to 20% sucrose in HB. Centrifuqation was carried out at 40,000 rpm for 10 hr at 4°C in a Beckman SW 50.1 rotor. Gradient fractions (0.2 ml) were collected and assayed for '*'I-mAb 35 binding in the standard DEAE column assay. Sedimentation markers included Torpedo electric organ AChR monomer (9 S) and dimer (13 S) labeled with ["51]-ol-BGT, catalase (11.3 S), and bacterial alkaline phosphatase (6.1 S) in parallel tubes as well as catalase in the same tube.
Cross-precipitation experiments. ol-Neurotoxin purified from the venom of Naja naja siamensis was conjugated to Sepharose Cl4B as previously described (Lindstrom et al., 1981) to yield 0.5 mg of conjugated toxrn/ml of Sepharose.
Reaction mixtures (0.085 ml liquid phase) were prepared containing the detergent extract from seven or eight ciliary ganglia, 5 nM '251-mAb 35 that had been passed through a DEAE cellulose column as described above, fetal calf serum at 1 mg of protein/ml, and either 0.015 or 0.030 ml of toxin-Sepharose.
Before recervrng the toxin-Sepharose, the reactions were incubated 1 hr at 4°C and then the combined mixtures were gently agitated overnight at 4°C. The toxin-Sepharose was collected by centrifugation In a Microfuge, washed five times with 1 ml of HB, and examined by gamma counting to determine the amount of bound '?mAb 35 (total binding). Nonspecific binding was determined by including 1.3 mg/ml of a-BGT along with the toxin-Sepharose, and was subtracted from total binding to yield specific binding for antigen-antibody complex to the toxin-Sepharose. A small amount of labeled antibody (-0.4 fmol) adsorbed to the toxin-Sepharose even in the absence of ciliary ganglion extract and was blocked by the 1.3 mg/ml of a-BGT; this background adsorption was also subtracted from the total binding. In parallel experiments the '251-mAb 35 was omitted, and the supernatant fraction recovered after centrifuging the toxin-Sepharose was tested for remaining a-BGT-binding sites rn the standard toxin-binding assay. To test for precrprtatron of toxin sites by antigen-anttbody complex, a 1 .lml detergent extract prepared with 83 citiary ganglia from-20.day-old chick embrvos was incubated in 10 nM I'Z511-ol-BGT for 2 hr at 4°C. The extract was then diluted 4-fold, divided into'aliquots, and incubated overnight at 4°C in duplrcate with rat antr-Torpedo antibodies (26 nM), mAb 35 (110 nM), or mAb 203 (178 nM) together with carrier normal rat serum. These concentrations represented an 1 l-, 58., and 45. times excess, respectively, of antrbody over antigen sites in the extract. Goat anti-rat IgG sufficient to preciprtate the rat antibody was then added, and after 4 hr at 4'C, the precipitate was collected by centrifugation, rinsed two times, and counted for gamma radiation. Substrtutton of normal rat serum for anti-receptor antibody was Vol. 5, No. 10, Oct. 1985 used to determine nonspecific binding and/or trapping of radioactivity in the precipitate. Alrquots of the original undiluted extract were incubated in parallel with 10 nM ['Z51]-a-BGT in the absence of antibody to assay for total wBGT binding.
Materials.
Torpedo AChR was purified from electric organ tissue and stored as previously described (Lindstrom et al., 1981 Results mAb 35 binding. Binding of '251-mAb 35 to the MIR-like component in chick ciliary ganglion extracts was measured by using a DEAE cellulose column to adsorb the antigen-antibody complex while allowing free antibody to pass through. Under standard conditions, formation of the antigen-antibody complex was complete in 15 min, and the amount of complex formed was directly proportional to the amount of extract (Fig. 1) . Near saturation of antigen was achieved at about 5 nM "51-mAb 35 (Fig. 2) . Scatchard analysis of the data from three separate experiments revealed a single class of high affinity mAb 35-binding sites with an apparent equilibrium dissociation constant, I$,, of 0.85 + 0.03 nM. For 17. to 18.day-old chick embryos, 7.4 f 0.7 (n = 3) fmol of antibody binding component were obtained per ciliary ganglion.
That Each value represents the mean f SEM of three experiments. None: no competing antibody; MAB35, 203, 6, and 43: mAbs 35, 203, 6 , and 43, respectively; NRS: normal rat serum.
Anti-MIR mAbs 6 and 203 blocked '*%mAb 35 binding nearly as efficiently as did mAb 35. No blockade of '251-mAb 35 binding was seen with mAb 43, a mAb of the same subclass as mAb 35 but of different specificity, or with normal rat serum at a comparable dilution of IgG. Lack of blockade in these cases did not reflect problems with the competition assay since mAb 35 was still able to prevent '"51-mAb 35 binding even in the presence of mAb 43 or normal rat serum (Fig. 3) .
Tissue distribution. The tissue distribution of the MIR-like component is consistent with that expected for a ganglionic AChR. High levels of '*%mAb 35 binding were obtained with extracts prepared from ciliary ganglia and sympathetic ganglia which are known to contain nicotinic AChRs. Little if any specific binding was detected in extracts of dorsal root ganglia, retina, spinal cord, heart, or liver (Fig. 4) .
Physical
properties.
The MIR-like antigen in the chick ciliary ganglion is an integral membrane component. All of the antibody binding sites (101 f l%, n = 3) were associated with membrane fragments in the absence of detergent, and most of the sites (80 + 9%, n = 5) were retained in the membrane after extraction with 1 M NaCI.
Moreover, the component is glycosylated, as expected for an integral membrane protein. con A conjugated to Sepharose beads was tested for its ability to deplete the MIR-like component from extracts. Nearly all of the MIR-like component was removed from solution by the con A-Sepharose (Table I) Tissue extracts were adjusted with HB to yield similar concentrations of protein and then were assayed for '?mAb 35 binding in the standard assay. Results represent the mean + SE for three to eight experiments for each tissue. CG, ciliary ganglia; SG, sympathetic ganglia; R, retina; DRG, dorsal root ganglia; SC, spinal cord; H, heart; L, liver.
TABLE I
Binding of the M/R-like component to con A-Sepharose Ciliary ganglion extracts were incubated under various conditions, centrifuged, and assayed for '*51-mAb 35.binding sites remaining In the supernatant fraction, as follows: None, no additives to the extract; con A-Seph, addition of con A-Sepharose to the extract; con A-Seph + blockers, addition of con A-Sepharose to the extract in the presence of 1 M cY-methyl-mannoside, 5 mM EGTA, and 5 mM EDTA; Elution of adsorbed con A-Seph, addition of con A-Seph to the extract, followed by centrifugation to collect the adsorbed con A-Sepharose, Incubation of the collected material in the blockers, recentrifugation to remove the con A-Sepharose, and assay of the recovered supernatant fraction for eluted antibody-blnding sites. Lu-methyl-mannoside in the presence of divalent cation chelators. Partial elution of the component after adsorption to the con ASepharose was achieved by treating the adsorbed material with (Ymethyl-mannoside and the chelators (Table I) .
Proportion of mAb 35 Sites Recovered
The sedimentation properties of the detergent-soluble material were examined by ultracentrifugation of ganglion extract through a sucrose gradient and assaying the recovered fractions for '251-mAb 35 binding in the standard assay. About two-thirds of the recovered MIR-like component migrated as a single species with a sedimentation coefficient of about 10 S (Fig. 5) . Co-precipitation. Ultrastructural studies have shown that most of the mAb 35.binding sites found on the surface of ciliary ganglion neurons in intact ganglia are different from cY-BGT-binding sites on the neurons since the antibody-binding sites occur largely in synaptic membrane, whereas the toxin sites are preferentially associated with dendritic membrane and appear to be excluded from synaptic membrane (Jacob and Berg, 1983; Jacob, et al., 1984) . However, some antibody binding was also detected on dendritic membranes where toxin binding was normally prominent (Jacob et al., 1984) . To determine whether the MIR-like component detected in ganglion extracts was distinct from the LU-BGT binding component, co-precipitation experiments were devised in which oc-neurotoxin from Naja naja siamensis venom was conjugated to Sepharose and the conjugate was used to adsorb the (w-BGT binding component. If the mAb 35.binding site were associated with the same molecule as the toxin site, "51-mAb 35 bound to antigen in the extract should have co-adsorbed to the Sepharose and should have been removed from the extract. The standard binding assays indicated at the outset that extracts prepared from 17-and l&day embryonic ganglia contain about 8 times as many a-BGT-binding sites as MIR-like component (data not shown). Under conditions in which 96% of the toxin sites were precipitated by the toxin-Sepharose, about 2% of the antibodybinding sites appeared to co-precipitate; i.e., the amount of 12?mAb 35 specifically associated with the toxin-Sepharose was equivalent on a molar basis to 2% of the number of mAb 35.binding sites present in the extract (Table II) . Lack of co-precipitation here cannot As an alternative approach to the same question, antibodies were used to precipitate the MIR-like antigen from ciliary ganglion extracts while monitoring the distribution of toxin sites during the procedure. Extracts were first incubated with lz51-a-BGT to label the toxin sites. Rat anti-Torpedo AChR antibodies, mAb 35, or mAb 203 were then added to bind the M/?-like antigen, and goat anti-rat IgG was added to precipitate the antigen-antibody complex. In each case the amount of precipitated toxin did not exceed 2% of the number of toxin sites known to be present in the extract. In repeat experiments with antiTorpedo AChR antibodies and with mAb 35, the precipitated toxin represented less than 4% of the sites in each case.
Development.
The amount of MIR-like component in the ciliary ganglion is developmentally regulated. A 6-fold increase occurred in the amount of component per ganglion between embryonic days 8 and 16 (Fig. 6A) . Little additional increase was seen up to 5 weeks post-hatch. When normalized for ganglionic protein, the specific activity of the MIR-like component reached a maximum at day 12 in the embryo and decreased markedly during the late embryonic and post-hatch periods (Fig. 6B ).
Discussion
The MIR-like component in the chick ciliary ganglion has several properties expected for a ganglionic nicotinic AChR. It shares a determinant with nicotinic AChRs from muscle and electric organ, It is an integral membrane component that sediments in detergent extracts primarily as a species of 10 S, a value close to that observed for AChR monomers from skeletal muscle and electric organ (Changeux et al., 1984) . The component binds to con A, and con A is known to block AChR function on the neurons (Messing et al., 1984) implying that con A interacts with the functional receptor. Of the tissues tested here, the component is restricted to those known to contain ganglionic AChRs. The greatest increase in specific activity of the MIR-like component in the ganglion occurs between embryonic days 8 and 12 when synapses are being consolidated in the ganglion (Landmesser and Pilar, 1972, 1978) . Previous studies on the distribution of surface components in the ganglion have demonstrated that the MIR-like component on the neuronal surface is located predominantly in the synaptic membrane (Jacob et al., 1984) .
Several of these points deserve additional comment. With respect to tissue distribution, relatively little mAb 35 binding was detected in extracts of chick retina although the tissue is known to contain nicotinic AChRs (Betz, 1981) . Either the retina receptors fail to bind mAb 35 or the heterogeneity of the tissue results in a specific activity for receptors (AChR per milligram of protein) too low for detection in the present assay. Anti-MIR mAb binding has previously been reported for the lateral spiriform nucleus of chick brain (Lindstrom et al., 1983 . Swanson et al., 1983 . Although functional AChRs have yet to be demonstrated in the nucleus, cross-reactivity was reported with mAbs specific for each of the subunits in AChR from muscle and electric organ. It is possible that the nucleus has ganglionic type AChRs.
The ultrastructural studies demonstrating a predominantly synaptic location for the MIR-like component were confined to surface sites (Jacob et al., 1984) . Frozen sections cut from the lateral spiriform nucleus (Swanson et al., 1983) and from the ciliary ganglion (M. Jacob and D. Berg, unpublished studies) indicate that substantial amounts of the MIR-like component appear to be intracellular. Studies in cell culture demonstrate that nearly two-thirds of the MIR-like component associated with ciliary ganglion neurons is intracellular (J. Stollberg, unpublished observations). If the same is true of the ganglion, much of the material examined here could represent an integral membrane component associated with intracellular membranes Although this seems surprising for a membrane receptor, it should be noted that both muscle AChRs and nerve growth factor receptors on cell lines sometimes have predominantly intracellular localizations (Olson et al., 1983; Ross et al., 1984 
